Much respect to Betonbio, Trader 388 and the other longs here.
I'm thinking of taking out a loan to purchase more SGYP- already own 3k shares but opportunity calls. Just wanted to get some opinions about the potential patent weakness that user Frontiers brought to attention on investment hub. The concern is that Synergy's patent on composition is only based on a single amino acid modification and if discovered to happen in nature will invalidate their patent on Plecanatide.
The article's title is "Plecanatide versus Linaclotide : Impending Patent Disaster for the Synergy Partner" and it is a couple pages long.